AVERAGE ANALYSTS PRICE TARGET $72
AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT
P/E RATIO
SHORT INTEREST 38%
COMPANY PROFILE
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. Its products include dried cannabis and cannabis extracts. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.
AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT
P/E RATIO
SHORT INTEREST 38%
COMPANY PROFILE
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. Its products include dried cannabis and cannabis extracts. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.